Outcome analysis of ventriculoperitoneal shunt procedures in hydrocephalus due to tubercular meningitis and non-infective cases

Devendra K. Tyagi; Srikant Balasubramaniam; Shalika A. Jayaswal; Hemant V. Savant; Anish S. Gandhi

doi:10.18203/2349-3291.ijcp20162788

Authors

Devendra K. Tyagi Department of Neurosurgery, T.N Medical College and B.Y.L. Nair Hospital, Mumbai Central, Mumbai
Srikant Balasubramaniam Department of Neurosurgery, T.N Medical College and B.Y.L. Nair Hospital, Mumbai Central, Mumbai
Shalika A. Jayaswal Department of Paediatric Surgery T.N Medical College and B.Y.L. Nair Hospital, Mumbai Central, Mumbai
Hemant V. Savant Department of Neurosurgery, T.N Medical College and B.Y.L. Nair Hospital, Mumbai Central, Mumbai
Anish S. Gandhi Department of Neurosurgery, T.N Medical College and B.Y.L. Nair Hospital, Mumbai Central, Mumbai

DOI:

https://doi.org/10.18203/2349-3291.ijcp20162788

Keywords:

Communicating hydrocephalus, Obstructive hydrocephalus, Tubercular Meningitis, Ventriculoperitoneal shunt

Abstract

Background:Hydrocephalus is one of the most common clinical conditions affecting the central nervous system. There have been several studies which show that the outcome of VP shunt in tubercular meningitis hydrocephalus is worse. We have conducted the present study to find whether VP shunt procedure complication rates are different in these two sub class patients or if the prognosis in TBM patients is worse due to the primary disease process.

Methods: Ours is a retrospective analysis conducted in a tertiary care centre of 50 patients each of hydrocephalus due to tubercular meningitis (TBM) and non-meningitis patients. The data was collected over a period of 3 years. The diagnosis of tubercular meningitis was established by clinical history with examination, cerebrospinal Fluid (CSF) analysis and computed tomography brain (CT - Plain and contrast). All patients underwent Ventriculo Peritoneal shunt (VPS) in a standard protocol. All patients of TBM were put on 4 drugs anti Kochs treatment (AKT) for 3 months and 2 drugs AKT for 1 year. The follow up ranged between 3 years to 6 years.

Results:Data in the form of age, sex, clinical signs/symptoms and shunt related complications were noted in a prescribed format. The complications in the two groups were statistically compared for significance using p value.

Conclusions:There is no statistically significant increase in complication rate of VP shunt in TBM patients versus non infective cases. The worse prognosis of TBM patients may probably be due to the primary disease process rather than functioning of shunt.

Metrics

Metrics Loading ...

References

Ahmed A, Sandlas G, Kothari P, Sarda D, Gupta A, Karkera P et al. Outcome analysis of shunt surgery in hydrocephalus. J Indian Assoc Pediatr Surg. 2009;14(3):98-101.

Vinchon M, Baroncini M, Delestret I. Adult outcome of pediatric hydrocephalus. Childs Nerv Syst. 2012;28:847-54.

Laurence KM, Coates S. The natural history of hydrocephalus: Detailed analysis of 182 unoperated cases. Arch Dis Child. 1962;37:345-62.

Bhaskar S. Management of hydrocephalus in tuberculous meningitis. Ann Indian Academy Neurol. 2012;15(3):231.

Rajshekhar V. Management of hydrocephalus in patients with tuberculous meningitis. Neurology India. 2009;57(4):368-74.

Sil K, Chatterjee S. Shunting in tuberculous meningitis: a neurosurgeon′s nightmare. Childs Nerv Syst. 2008;24:1029-32.

Agrawal D, Gupta A, Mehta VS. Role of shunt surgery in paediatric tubercular meningitis with hydrocephalus. Indian Pediatr. 2005;42:245-50.

Palur R, Rajshekhar V, Chandy MJ, Joseph T, Abraham J. Shunt surgery for hydrocephalus in tubercular meningitis: A long term follow up study. J Neurosurg. 1991;74:64-9.

Tandon PN. Tuberculous meningitis (cranial and spinal). In: Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology. Infections of the Nervous System. vol. 33. Amsterdam: North-Holland; 1978:195-262.

Schoeman J, Donald P, van Zyl L, Keet M, Wait J. Tuberculous hydrocephalus: Comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol 1991;33:396-405.

Ahuja GK, Mohan KK, Prasad K, Behari M. Diagnostic criteria for tuberculous meningitis and their validation. Tuber Lung Dis. 1994;75:149-52.

Pai M, Zwerling A, Menzies D. T-cell based assays forthe diagnosis of latent tuberculosis infection: An update. Ann Intern Med. 2008;149:177-84.

Murthy JM. Tuberculous meningitis: The challenges. Neurol India. 2010;58:716-22.

Kulkarni SP, Jaleel MA, Kadival GV. Evaluation of an in-house-developed PCR for the diagnosis of tubertculous meningitis in Indian children. J Med Microbiol. 2005;54:369-73.

Chandramukhi A, Bothamley GH, Brennan PJ, Ivanyi J. Levels of antibody to detect antigens of mycobacterium tuberculosis in tuberculous meningitis. J Clin Microbiol. 1989;27:821-5.

Williams B. Is aqueduct Stenosis a result of hydrocephalus? Brain. 1973;96:399-412.

McLone DG, Knepper PA. The cause of Chiari II malformation: a unified theory. Pediatr Neurosurg. 1989;14:1-12.

Yadav YR, Jaiswal S, Adam N, Basoor A, Jain G. Endoscopic third ventriculostomy in infants. Neurol India. 2006;54:161-3.

Fouyas IP, Casey AH, Thompson DN, Hayward D, Harkness WF, Hayward RD, et al. Use of intracranial pressure monitoring in the management of childhood hydrocephalus and shunt-related problems. Neurosurgery. 1996;38:726-32.

Kumar V, Phipps K, Harkness W, Hayward RD. Ventriculo-peritoneal shunt requirement in children with posterior fossa tumours: an 11-year audit. Br J Neurosurg. 1996;10(5):467-70.

Griwan MS, Sharma BS, Mahajan RK, Kak VK. Value of precraniotomy shunts in children with posterior fossa tumours. Childs Nerv Syst. 1993;9(8):462-5.

Abou-Madawi A. VP-Shunt Requirement in Patients with Posterior Fossa tumors. Suez Canal Univ Med J. 2007;10(2):121-8.

Reddy GK, Bollam P, Caldito G. Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus. World Neurosurg 2014; 81(2): 404-10.

Bierbrauer KS, Storrs BB, McLone DG, Tomita T, Dauser R. A prospective, randomized study of shunt function and infections as a function of shunt placement. Pediatr Neurosurg. 1990;16:287-9.

Choux M, Genitori L, Lang D, Lena G. Shunt implantation: Reducing the incidence of shunt infection. J Neurosurg. 1992;77:875-80.